7065837
Human Neuropilin-1 Antibody, R&D Systems™
Mouse Monoclonal Antibody has been used in 2 publications
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
Neuropilin-1
Concentration
LYOPH
Applications
Western Blot
Conjugate
Unconjugated
Host Species
Mouse
Target Species
Human
Gene Accession No.
NP_001019799
Gene ID (Entrez)
8829
Immunogen
Mouse myeloma cell line NS0-derived recombinant human Neuropilin-1 Phe22-Lys644 Accession # NP_001019799
Primary or Secondary
Primary
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity
Detects human Neuropilin-1 in direct ELISAs and Western blots. In direct ELISAs and Western blots, this antibody does not cross-react with recombinant rat (rr) Neuropilin-1 or rhNeuropilin-2.
Clone
446915
Dilution
Western Blot 1 ug/mL
Classification
Monoclonal
Form
Purified
Regulatory Status
RUO
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias
BDCA4, BDCA-4, CD304, CD304 antigen, DKFZp686A03134, DKFZp781F1414, neuropilin 1, neuropilin-1, Neuropilin1, NP1, NRP, NRP1, transmembrane receptor, Vascular endothelial cell growth factor 165 receptor, VEGF165R
Gene Symbols
NRP1
Isotype
IgG1
Purification Method
Protein A or G purified from hybridoma culture supernatant
Content And Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Description
- Neuropilin-1 Monoclonal specifically detects Neuropilin-1 in Human samples
- It is validated for Western Blot.
Compare Similar Items
Show Difference
Antigen: Neuropilin-1
Concentration: LYOPH
Applications: Western Blot
Conjugate: Unconjugated
Host Species: Mouse
Target Species: Human
Gene Accession No.: NP_001019799
Gene ID (Entrez): 8829
Immunogen: Mouse myeloma cell line NS0-derived recombinant human Neuropilin-1 Phe22-Lys644 Accession # NP_001019799
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity: Detects human Neuropilin-1 in direct ELISAs and Western blots. In direct ELISAs and Western blots, this antibody does not cross-react with recombinant rat (rr) Neuropilin-1 or rhNeuropilin-2.
Clone: 446915
Dilution: Western Blot 1 ug/mL
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias: BDCA4, BDCA-4, CD304, CD304 antigen, DKFZp686A03134, DKFZp781F1414, neuropilin 1, neuropilin-1, Neuropilin1, NP1, NRP, NRP1, transmembrane receptor, Vascular endothelial cell growth factor 165 receptor, VEGF165R
Gene Symbols: NRP1
Isotype: IgG1
Purification Method: Protein A or G purified from hybridoma culture supernatant
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Antigen:
Neuropilin-1
Concentration:
LYOPH
Applications:
Western Blot
Conjugate:
Unconjugated
Host Species:
Mouse
Target Species:
Human
Gene Accession No.:
NP_001019799
Gene ID (Entrez):
8829
Immunogen:
Mouse myeloma cell line NS0-derived recombinant human Neuropilin-1 Phe22-Lys644 Accession # NP_001019799
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity:
Detects human Neuropilin-1 in direct ELISAs and Western blots. In direct ELISAs and Western blots, this antibody does not cross-react with recombinant rat (rr) Neuropilin-1 or rhNeuropilin-2.
Clone:
446915
Dilution:
Western Blot 1 ug/mL
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias:
BDCA4, BDCA-4, CD304, CD304 antigen, DKFZp686A03134, DKFZp781F1414, neuropilin 1, neuropilin-1, Neuropilin1, NP1, NRP, NRP1, transmembrane receptor, Vascular endothelial cell growth factor 165 receptor, VEGF165R
Gene Symbols:
NRP1
Isotype:
IgG1
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Antigen: Neurturin
Concentration: __
Applications: Western Blot, ELISA, Blockade of Receptor-ligand Interaction
Conjugate: Unconjugated
Host Species: Mouse
Target Species: Human
Gene Accession No.: Q99748
Gene ID (Entrez): 4902
Immunogen: E. coli-derived recombinant human Neurturin Ala96-Val197 Accession # Q99748
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity: Detects human Neurturin in direct ELISAs and Western blots. In sandwich immunoassays, no cross-reactivity with recombinant mouse Neurturin, recombinant human (rh) TGF-alpha , rhTGF-beta 2, rhTGF-beta 1.2, rhTGF-beta 3, rhGDNF, rhLAP, or recombinant rat TGF-beta 5 is observed.
Clone: 126424
Dilution: Western Blot 1 ug/mL, ELISA, Blockade of Receptor-ligand Interaction
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias: neurturin, NRTN, NTN
Gene Symbols: NRTN
Isotype: IgG1
Purification Method: Protein A or G purified from hybridoma culture supernatant
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Antigen:
Neurturin
Concentration:
__
Applications:
Western Blot, ELISA, Blockade of Receptor-ligand Interaction
Conjugate:
Unconjugated
Host Species:
Mouse
Target Species:
Human
Gene Accession No.:
Q99748
Gene ID (Entrez):
4902
Immunogen:
E. coli-derived recombinant human Neurturin Ala96-Val197 Accession # Q99748
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity:
Detects human Neurturin in direct ELISAs and Western blots. In sandwich immunoassays, no cross-reactivity with recombinant mouse Neurturin, recombinant human (rh) TGF-alpha , rhTGF-beta 2, rhTGF-beta 1.2, rhTGF-beta 3, rhGDNF, rhLAP, or recombinant rat TGF-beta 5 is observed.
Clone:
126424
Dilution:
Western Blot 1 ug/mL, ELISA, Blockade of Receptor-ligand Interaction
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias:
neurturin, NRTN, NTN
Gene Symbols:
NRTN
Isotype:
IgG1
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Antigen: Proprotein Convertase 9/PCSK9
Concentration: LYOPH
Applications: Western Blot, Immunoprecipitation
Conjugate: Unconjugated
Host Species: Rat
Target Species: Human
Gene Accession No.: Q8NBP7
Gene ID (Entrez): 255738
Immunogen: Mouse myeloma cell line NS0-derived recombinant human Proprotein Convertase 9/PCSK9 Arg29-Gln692 Accession # Q8NBP7
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity: Detects human Proprotein Convertase 9/PCSK9 in direct ELISAs and Western blots. In Western blots, 10% cross-reactivity with recombinant mouse PCSK9 is observed and no cross-reactivity with recombinant human (rh) PCSK1 or rhPCSK7 is observed.
Clone: 499911
Dilution: Western Blot 1 ug/mL, Immunoprecipitation 25 ug/mL
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias: EC 3.4.21, EC 3.4.21.111, FH3, FH3neural apoptosis regulated convertase 1, FHCL3, HCHOLA3, hypercholesterolemia, autosomal dominant 3, LDLCQ1, NARC1, NARC-1, NARC-1convertase subtilisin/kexin type 9 preproprotein, NARC1EC 3.4.21.-, Neural apoptosis-regulated convertase 1, PC9, PCSK9, Proprotein convertase 9, proprotein convertase subtilisin/kexin type 9, Subtilisin/kexin-like protease PC9
Gene Symbols: PCSK9
Isotype: IgG2b
Purification Method: Protein A or G purified from hybridoma culture supernatant
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Antigen:
Proprotein Convertase 9/PCSK9
Concentration:
LYOPH
Applications:
Western Blot, Immunoprecipitation
Conjugate:
Unconjugated
Host Species:
Rat
Target Species:
Human
Gene Accession No.:
Q8NBP7
Gene ID (Entrez):
255738
Immunogen:
Mouse myeloma cell line NS0-derived recombinant human Proprotein Convertase 9/PCSK9 Arg29-Gln692 Accession # Q8NBP7
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity:
Detects human Proprotein Convertase 9/PCSK9 in direct ELISAs and Western blots. In Western blots, 10% cross-reactivity with recombinant mouse PCSK9 is observed and no cross-reactivity with recombinant human (rh) PCSK1 or rhPCSK7 is observed.
Clone:
499911
Dilution:
Western Blot 1 ug/mL, Immunoprecipitation 25 ug/mL
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias:
EC 3.4.21, EC 3.4.21.111, FH3, FH3neural apoptosis regulated convertase 1, FHCL3, HCHOLA3, hypercholesterolemia, autosomal dominant 3, LDLCQ1, NARC1, NARC-1, NARC-1convertase subtilisin/kexin type 9 preproprotein, NARC1EC 3.4.21.-, Neural apoptosis-regulated convertase 1, PC9, PCSK9, Proprotein convertase 9, proprotein convertase subtilisin/kexin type 9, Subtilisin/kexin-like protease PC9
Gene Symbols:
PCSK9
Isotype:
IgG2b
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Antigen: KOR
Concentration: LYOPH
Applications: Flow Cytometry, Immunocytochemistry, CyTOF
Conjugate: Unconjugated
Host Species: Mouse
Target Species: Human
Gene Accession No.: P41145
Gene ID (Entrez): 4986
Immunogen: NS0 mouse myeloma cell line transfected with human KOR Met1-Val380 Accession # P41145
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity: Detects human KOR. Stains human KOR transfectants but not irrelevant transfectants.
Clone: 387301
Dilution: Flow Cytometry 0.25 ug/10^6 cells, Immunocytochemistry 8-25 ug/mL, CyTOF-ready
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias: kappa opioid receptor, kappa-type opioid receptor, KOR, K-OR-1, KOR-1, Opiate receptor, kappa-1, opioid receptor, kappa 1, OPRK, OPRK1, Oprk2, R21
Gene Symbols: OPRK1
Isotype: IgG1
Purification Method: Protein A or G purified from hybridoma culture supernatant
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Antigen:
KOR
Concentration:
LYOPH
Applications:
Flow Cytometry, Immunocytochemistry, CyTOF
Conjugate:
Unconjugated
Host Species:
Mouse
Target Species:
Human
Gene Accession No.:
P41145
Gene ID (Entrez):
4986
Immunogen:
NS0 mouse myeloma cell line transfected with human KOR Met1-Val380 Accession # P41145
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Test Specificity:
Detects human KOR. Stains human KOR transfectants but not irrelevant transfectants.
Clone:
387301
Dilution:
Flow Cytometry 0.25 ug/10^6 cells, Immunocytochemistry 8-25 ug/mL, CyTOF-ready
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias:
kappa opioid receptor, kappa-type opioid receptor, KOR, K-OR-1, KOR-1, Opiate receptor, kappa-1, opioid receptor, kappa 1, OPRK, OPRK1, Oprk2, R21
Gene Symbols:
OPRK1
Isotype:
IgG1
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.